NM_004937.3(CTNS):c.771_793del (p.Gly258fs) AND Cystinosis
- Germline classification:
- Pathogenic (3 submissions)
- Last evaluated:
- Jul 5, 2017
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV000586519.12
Allele description [Variation Report for NM_004937.3(CTNS):c.771_793del (p.Gly258fs)]
NM_004937.3(CTNS):c.771_793del (p.Gly258fs)
Condition(s)
- Name:
- Cystinosis
- Synonyms:
- Cystine diathesis; Cystine disease; Cystine storage disease; See all synonyms [MedGen]
- Identifiers:
- MONDO: MONDO:0016239; MedGen: C4316899
-
autophagy protein 5 [Vitis vinifera]
autophagy protein 5 [Vitis vinifera]gi|225427089|ref|XP_002276604.1|Protein
-
Microcosting details for Walking Away and Walking Away Plus - Behavioural interv...
Microcosting details for Walking Away and Walking Away Plus - Behavioural interventions to promote physical activity in a multiethnic population at high risk of diabetes: PROPELS three-arm RCT
-
Overview of acceptability evidence by study interventions - The effectiveness, a...
Overview of acceptability evidence by study interventions - The effectiveness, acceptability and cost-effectiveness of psychosocial interventions for maltreated children and adolescents: an evidence synthesis
-
List of abbreviations - Palivizumab for Immunoprophylaxis of Respiratory Syncyti...
List of abbreviations - Palivizumab for Immunoprophylaxis of Respiratory Syncytial Virus (RSV) Bronchiolitis in High-Risk Infants and Young Children: Systematic Review and Additional Economic Modelling of Subgroup Analyses
-
Qualitative research study profiles - OPTIMA prelim: a randomised feasibility st...
Qualitative research study profiles - OPTIMA prelim: a randomised feasibility study of personalised care in the treatment of women with early breast cancer
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Oct 26, 2024